Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ROLE OF HEPARIN TO PREVENT HYPERTROPHIC SCARNIG IN DONOR AREA OF SPLIT THICKNESS SKIN GRAFT

NCT07196358 is registered in ClinicalTrials.gov with Dr. Ruth K.M. Pfau Civil Hospital, Karachi as lead sponsor.

NCT NCT07196358
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07196358 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ROLE OF HEPARIN TO PREVENT HYPERTROPHIC SCARNIG IN DONOR AREA OF SPLIT THICKNESS SKIN GRAFT
Lead sponsor
Dr. Ruth K.M. Pfau Civil Hospital, Karachi
Phase
Not applicable
Overall status
Completed
Start date
August 15, 2024
Completion date
September 10, 2025
Enrollment
400 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertrophic scarring, pain, postoperative, wound healing